Losartan Impurity 22

Product Description
CAT No.
ALN-L028057
CAS No.
NA
Mol. F.
C22H24ClN9
Mol. Wt.
449.9
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 5-4-((5-(azidomethyl)-2-butyl-4-chloro-1H-imidazole-1yl)methyl)(1,1-biphenyl)-2yl-1H-tetrazole
Smiles : ClC1=C(CN=[N+]=[N-])N(CN2N=NNC2C3=CC=CC=C3C4=CC=CC=C4)C(CCCC)=N1
Inchi : InChI=1/C51H82N8O17/c1-6-25(2)19-26(3)13-11-9-7-8-10-12-14-37(66)53-32-21-35(64)47(72)57-49(74)41-42(67)27(4)23-59(41)51(76)39(34(63)22-36(52)65)55-48(73)40(44(69)43(68)29-15-17-30(61)18-16-29)56-46(71)33-20-31(62)24-58(33)50(75)38(28(5)60)54-45(32)70/h15-18,25-28,31-35,38-44,47,60-64,67-69,72H,6-14,19-24H2,1-5H3,(H2,52,65)(H,53,66)(H,54,70)(H,55,73)(H,56,71)(H,57,74)
Technical Data
Reference
Development and validation of a stability-indicating HPLC method for the simultaneous determination of Losartan potassium, hydrochlorothiazide, and their degradation products
Deanne L. Hertzog a,*, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. ReednJournal of Pharmaceutical and Biomedical Analysis 30 (2002) 747u2013760
An Efficient, Commercially Viable, and Safe Process for Preparation of Losartan Potassium, an Angiotensin II Receptor Antagonist
, Jennifer Finnegan McCafferty b , Xueguang Fang b , R. Jeffrey Tyrrell c , Robert A. Reed – Journal of Pharmaceutical and Biomedical Analysis 30 (2002) 747–760
Suri Babu Madasu,†,‡ N. A. Vekariya,
RFQ